ANIXNasdaqPharmaceutical PreparationsFiscal year ends October 31
Anixa Biosciences Inc
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026
$2.61−0.06 (-2.25%)
Close on Oct 19, 2026
- Market cap
- $89.22M
- P/E (TTM)
- –
- Dividend yield
- –
Charting library not installed
Copy the licensed TradingView charting_library folder to apps/web/public/charting_library/, or set TV_LIBRARY_PATH, then reload. Setup steps are in docs/ADVANCED-CHARTS.md.